These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39389423)

  • 1. Current status and challenges of model-informed drug discovery and development in China.
    Wang Y; Ji J; Yao Y; Nie J; Xie F; Xie Y; Li G
    Adv Drug Deliv Rev; 2024 Nov; 214():115459. PubMed ID: 39389423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future.
    Wu YE; Zheng YY; Li QY; Yao BF; Cao J; Liu HX; Hao GX; van den Anker J; Zheng Y; Zhao W
    Adv Drug Deliv Rev; 2024 Aug; 211():115364. PubMed ID: 38936664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Model-Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling.
    Bi Y; Liu J; Li L; Yu J; Bhattaram A; Bewernitz M; Li RJ; Liu C; Earp J; Ma L; Zhuang L; Yang Y; Zhang X; Zhu H; Wang Y
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S104-S111. PubMed ID: 31502691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Modern Curriculum for Training Scientists in Model-Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists.
    Barrett JS; Romero K; Rayner C; Gastonguay M; Pillai GC; Tannenbaum S; Kern S; Selich M; Francisco D
    Clin Pharmacol Ther; 2024 Aug; 116(2):289-294. PubMed ID: 39012325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
    Rayner CR; Smith PF; Andes D; Andrews K; Derendorf H; Friberg LE; Hanna D; Lepak A; Mills E; Polasek TM; Roberts JA; Schuck V; Shelton MJ; Wesche D; Rowland-Yeo K
    Clin Pharmacol Ther; 2021 Apr; 109(4):867-891. PubMed ID: 33555032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making.
    Madabushi R; Seo P; Zhao L; Tegenge M; Zhu H
    Pharm Res; 2022 Aug; 39(8):1669-1680. PubMed ID: 35552984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation.
    Kuemmel C; Yang Y; Zhang X; Florian J; Zhu H; Tegenge M; Huang SM; Wang Y; Morrison T; Zineh I
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):21-28. PubMed ID: 31652029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An AI Approach to Generating MIDD Assets Across the Drug Development Continuum.
    Barrett JS; Goyal RK; Gobburu J; Baran S; Varshney J
    AAPS J; 2023 Jul; 25(4):70. PubMed ID: 37430126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives.
    Mak WY; He Q; Yang W; Xu N; Zheng A; Chen M; Lin J; Shi Y; Xiang X; Zhu X
    Adv Drug Deliv Rev; 2024 Nov; 214():115447. PubMed ID: 39277035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Drug Development and Regulatory Science in China.
    Chen J; Zhao N
    Ther Innov Regul Sci; 2018 Nov; 52(6):739-750. PubMed ID: 29714583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities.
    Al-Huniti N; Feng Y; Yu JJ; Lu Z; Nagase M; Zhou D; Sheng J
    CPT Pharmacometrics Syst Pharmacol; 2020 Aug; 9(8):419-427. PubMed ID: 32589767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance.
    Huanbutta K; Burapapadh K; Kraisit P; Sriamornsak P; Ganokratanaa T; Suwanpitak K; Sangnim T
    Eur J Pharm Sci; 2024 Dec; 203():106938. PubMed ID: 39419129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Model-Informed Drug Development in Dose Selection and Optimization for siRNA Therapies.
    Yuan Y; Li L; Earp J; Ma L; Bhattaram VA; Sharma V; Tong A; Wang Y; Liu J; Zhu H
    J Clin Pharmacol; 2024 Jul; 64(7):799-809. PubMed ID: 38426370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future.
    Rowland Yeo K; Gil Berglund E; Chen Y
    Clin Pharmacol Ther; 2024 Sep; 116(3):563-576. PubMed ID: 38686708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-Informed Drug Development Approaches to Assist New Drug Development in the COVID-19 Pandemic.
    Xiong Y; Fan J; Kitabi E; Zhang X; Bi Y; Grimstein M; Yang Y; Earp JC; Zheng N; Liu J; Wang Y; Zhu H
    Clin Pharmacol Ther; 2022 Mar; 111(3):572-578. PubMed ID: 34807992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities.
    Terranova N; Venkatakrishnan K; Benincosa LJ
    AAPS J; 2021 May; 23(4):74. PubMed ID: 34008139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences and initiatives on pharmacokinetic modeling and simulation data analysis: Perspectives from the Brazilian Health Regulatory Agency (ANVISA).
    Borges LN; Fernandes EAF; Oliveira ÉM; Pereira VG; Diniz A
    Regul Toxicol Pharmacol; 2024 Dec; 154():105728. PubMed ID: 39442666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can natural language processing help model informed drug development?: a review.
    Bhatnagar R; Sardar S; Beheshti M; Podichetty JT
    JAMIA Open; 2022 Jul; 5(2):ooac043. PubMed ID: 35702625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-Informed Drug Development in Pediatric Dose Selection.
    Bi Y; Liu J; Li F; Yu J; Bhattaram A; Bewernitz M; Li RJ; Ahn J; Earp J; Ma L; Zhuang L; Yang Y; Zhang X; Zhu H; Wang Y
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S60-S69. PubMed ID: 34185906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.